ArticleEuropean journal of clinical pharmacology2016

High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.

Rehana Jamani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.